CVS Health Corp (CVS) is now in the Undervalued zone, suggesting that its current forward PE ratio of 11.66 is considered Undervalued compared with the five-year average of 10.23. The fair price of CVS Health Corp (CVS) is between 81.17 to 96.82 according to relative valuation method. Compared to the current price of 81.07 USD , CVS Health Corp By Undervalued By 0.12%.

Relative Value

Fair Zone

81.17-96.82

Current Price：81.07

0.12%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is CVS Health Corp (CVS) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

CVS Health Corp (CVS) has a current Price-to-Book (P/B) ratio of 1.40. Compared to its 3-year average P/B ratio of 1.15, the current P/B ratio is approximately 21.18% higher. Relative to its 5-year average P/B ratio of 1.36, the current P/B ratio is about 2.32% higher. CVS Health Corp (CVS) has a Forward Free Cash Flow (FCF) yield of approximately 6.19%. Compared to its 3-year average FCF yield of 9.98%, the current FCF yield is approximately -38.03% lower. Relative to its 5-year average FCF yield of 11.00%, the current FCF yield is about -43.77% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for CVS competitors is 0.77, providing a benchmark for relative valuation. CVS Health Corp Corp (CVS.N) exhibits a P/S ratio of 0.25, which is -67.36% above the industry average. Given its robust revenue growth of 8.17%, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of CVS increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of CVS in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is CVS currently overvalued or undervalued?

What is CVS Health Corp (CVS) fair value?

CVS's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of CVS Health Corp (CVS) is between 81.17 to 96.82 according to relative valuation method.

How does CVS's valuation metrics compare to the industry average?

The average P/S ratio for CVS's competitors is 0.77, providing a benchmark for relative valuation. CVS Health Corp Corp (CVS) exhibits a P/S ratio of 0.25, which is -67.36% above the industry average. Given its robust revenue growth of 8.17%, this premium appears unsustainable.

What is the current P/B ratio for CVS Health Corp (CVS) as of Mar 02 2026?

As of Mar 02 2026, CVS Health Corp (CVS) has a P/B ratio of 1.40. This indicates that the market values CVS at 1.40 times its book value.

What is the current FCF Yield for CVS Health Corp (CVS) as of Mar 02 2026?

As of Mar 02 2026, CVS Health Corp (CVS) has a FCF Yield of 6.19%. This means that for every dollar of CVS Health Corp's market capitalization, the company generates 6.19 cents in free cash flow.

What is the current Forward P/E ratio for CVS Health Corp (CVS) as of Mar 02 2026?

As of Mar 02 2026, CVS Health Corp (CVS) has a Forward P/E ratio of 11.66. This means the market is willing to pay $11.66 for every dollar of CVS Health Corp's expected earnings over the next 12 months.

What is the current Forward P/S ratio for CVS Health Corp (CVS) as of Mar 02 2026?

As of Mar 02 2026, CVS Health Corp (CVS) has a Forward P/S ratio of 0.25. This means the market is valuing CVS at $0.25 for every dollar of expected revenue over the next 12 months.

CVS Valuation